Company profile XENE
There is not enough data for Xenon Pharmaceuticals login to provide analysis
There is not enough data for Xenon Pharmaceuticals login to provide correlation calculation
There is not enough data for Xenon Pharmaceuticals login to provide analysis
After 39 days of this quarter the interest is at 74.0. Based on that we can calculate that during remaining 52 days it will total up to 173.0. Xenon Pharmaceuticals stock expected interest is significantly higher compared to same quarter last year (+137.0%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 25 | 62 148.0% QoQ | 55 -11.3% QoQ | 63 14.5% QoQ |
| 2020 | 16 -36.0% YoY -74.6% QoQ | 58 -6.5% YoY 262.5% QoQ | 73 32.7% YoY 25.9% QoQ | 66 4.8% YoY -9.6% QoQ |
| 2021 | 89 456.2% YoY 34.8% QoQ | 87 50.0% YoY -2.2% QoQ | 193 164.4% YoY 121.8% QoQ | 228 245.5% YoY 18.1% QoQ |
| 2022 | 167 87.6% YoY -26.8% QoQ | 92 5.7% YoY -44.9% QoQ | 142 -26.4% YoY 54.3% QoQ | 44 -80.7% YoY -69.0% QoQ |
| 2023 | 73 -56.3% YoY 65.9% QoQ | 170 84.8% YoY 132.9% QoQ | 78 -45.1% YoY -54.1% QoQ | 127 188.6% YoY 62.8% QoQ |
| 2024 | 74 1.4% YoY -41.7% QoQ | - | - | - |
The average 5 years interest of Xenon Pharmaceuticals stock was 7.59 per week. The last year interest of Xenon Pharmaceuticals stock compared to the last 5 years has changed by 28.46%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 129.41%.
There is not enough data for Xenon Pharmaceuticals treatments to provide analysis
There is not enough data for Xenon Pharmaceuticals treatments to provide correlation calculation
There is not enough data for Xenon Pharmaceuticals treatments to provide analysis
There is not enough data for XEN496 clinical trials to provide analysis
There is not enough data for XEN496 clinical trials to provide correlation calculation
There is not enough data for XEN496 clinical trials to provide analysis
There is not enough data for XEN1101 phase 2 trial to provide analysis
There is not enough data for XEN1101 phase 2 trial to provide correlation calculation
There is not enough data for XEN1101 phase 2 trial to provide analysis
There is not enough data for NBI-921352 phase 2 trial to provide analysis
There is not enough data for NBI-921352 phase 2 trial to provide correlation calculation
There is not enough data for NBI-921352 phase 2 trial to provide analysis
There is not enough data for potassium channel opener to provide analysis
There is not enough data for potassium channel opener to provide correlation calculation
There is not enough data for potassium channel opener to provide analysis
After 39 days of this quarter the interest is at 81.0. Based on that we can calculate that during remaining 52 days it will total up to 189.0. neurological disorders treatment expected interest is significantly lower compared to previous quarter (-50.1%) and same quarter last year (-41.8%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 101 | 109 7.9% QoQ | 22 -79.8% QoQ | 141 540.9% QoQ |
| 2020 | 179 77.2% YoY 27.0% QoQ | 176 61.5% YoY -1.7% QoQ | 196 790.9% YoY 11.4% QoQ | 131 -7.1% YoY -33.2% QoQ |
| 2021 | 264 47.5% YoY 101.5% QoQ | 160 -9.1% YoY -39.4% QoQ | 295 50.5% YoY 84.4% QoQ | 163 24.4% YoY -44.7% QoQ |
| 2022 | 224 -15.2% YoY 37.4% QoQ | 289 80.6% YoY 29.0% QoQ | 144 -51.2% YoY -50.2% QoQ | 311 90.8% YoY 116.0% QoQ |
| 2023 | 325 45.1% YoY 4.5% QoQ | 307 6.2% YoY -5.5% QoQ | 145 0.7% YoY -52.8% QoQ | 379 21.9% YoY 161.4% QoQ |
| 2024 | 81 -75.1% YoY -78.6% QoQ | - | - | - |
The average 5 years interest of neurological disorders treatment was 15.87 per week. The last year interest of neurological disorders treatment compared to the last 5 years has changed by 32.83%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 119.58%.
There is not enough data for KCNQ2 developmental and epileptic encephalopathy to provide analysis
There is not enough data for KCNQ2 developmental and epileptic encephalopathy to provide correlation calculation
There is not enough data for KCNQ2 developmental and epileptic encephalopathy to provide analysis
There is not enough data for SCN8A developmental and epileptic encephalopathy to provide analysis
There is not enough data for SCN8A developmental and epileptic encephalopathy to provide correlation calculation
There is not enough data for SCN8A developmental and epileptic encephalopathy to provide analysis
There is not enough data for Neurocrine Biosciences collaboration. to provide analysis
There is not enough data for Neurocrine Biosciences collaboration. to provide correlation calculation
There is not enough data for Neurocrine Biosciences collaboration. to provide analysis
Useful links and data for XENE
Latest articles
Warning: Invalid argument supplied for foreach() in /data/web/virtuals/197504/virtual/www/domains/twimm.cz/socialarb/company.php on line 515